Well I guess it was today after all, and it turns out to be 9 million instead of 7 million. I dont know if that's good or bad (more dilution, but apparently more interest in owning the stock).
DJ ViroPharma 9M-Shr Offering Priced at $16 Each ?
06 Dec 20:18
NEW YORK (Dow Jones)--ViroPharma Inc.'s (VPHM) secondary offering of 9 million shares was priced at $16 each.
The company previously expected to offer 7 million shares.
Last month, the company said it would grant the underwriters the option to purchase up to an addtional 1.05 million shares.
Goldman Sachs & Co. was sole book-running manager for the offering. Piper Jaffray & Co. was the joint lead manager and SG Cowen & Co. LLC and Lazard Capital Markets LLC were co-managers of the offering.
ViroPharma intends to use net proceeds from the offering for working capital and general corporate purposes. The company also said it may use a portion of the net proceeds to repay or prepay all or a portion of its 6% subordinated convertible notes due March 2007 and for business development purposes.
-Freddy Sebastian; Dow Jones Newswires; 201-938-5400; AskNewswires@dowjones.com
Order free Annual Report for ViroPharma Incorporated Visit http://djnewswires.ar.wilink.com/?link=VPHM or call 1-888-301-0513 (END) Dow Jones Newswires 12-06-05 2018ET Copyright (c) 2005 Dow Jones & Company, Inc.